Howard A. Liebman

Professor of Medicine Director, Fellowship Program in Hematology Medical Director, Special Hemostasis Laboratory, Norris Cancer Hospital Director, University of Southern California, Gaucher Center
Liebman,-Howard_retouched

Areas of treatment:

Thrombotic and Bleeding Disorders
Immune Blood Disorders
Bone Marrow Failure Syndromes

Specialty:

  • Hematology and Oncology

Department:

  • Department of Medicine

Language:

  • English
best doctor

Howard A. Liebman, MD

Professor of Medicine
Director, Fellowship Program in Hematology
Medical Director, Special Hemostasis Laboratory, Norris Cancer Hospital
Director, University of Southern California, Gaucher Center

Practicing location:

  • USC Norris Comprehensive Cancer Center and Hospital

About this doctor:

Since 1999, Dr. Liebman is the author or co-author of over 100 medical articles and chapters and has led well over a hundred lectures across the United States, South America, Europe and Japan on a variety of medical topics. He has also been the recipient of millions of dollars in research grants, reviewed a number of medical journals and is a former Chair of the Massachusetts Governor’s Task Force subcommittee on experimental therapies and clinical trials for AIDS.  In addition to his academic responsibilities, Dr. Liebman is an attending staff member of the LAC+USC Medical Center, the USC/Norris Comprehensive Cancer Center and the Keck Hospital of USC.

Dr. Liebman also is on the forefront of research in thrombotic and hemorrhagic disorders.  His lab is currently studying the genetic risk factors responsible for thrombotic diseases including venous thrombosis, pulmonary embolism, arterial thrombosis and thrombosis associated with cancer chemotherapy. Additional studies are elucidating the role of prothrombotic defects in developing osteonecrosis.  He has also been the principle investigator on a number of clinical trials in the management of immune thrombocytopenia.  His research group has made important discoveries on the role of infectious agents in the development of immune thrombocytopenia.  Dr. Liebman is also internationally known for his work in the relationships between venous thrombotic disease and underlying malignancy and has served on the Cancer and Thrombosis Guideline Committee of the American Society of Clinical Oncology.

http://internalmedicine.usc.edu/specialties/hematology/

Education:

Occidental College, Los Angeles, CA, B.A. (History), 1968
Occidental College, Los Angeles, CA, M.A.(Biology), 1969
University of Southern California, Los Angeles, CA, M.D., 1973

Internships:

LAC+USC Medical Center (Internal Medicine), Los Angeles, CA, 1973 - 1974

Residencies:

LAC+USC Medical Center (Internal Medicine), Los Angeles, CA, 1974 - 1976

Fellowships:

LAC+USC Medical Center (Oncology), Los Angeles, CA, 1976 - 1978
LAC+USC Medical Center (Hematology), Los Angeles, CA, 1978 - 1980
Tufts University, New England Medical Center (Research Fellow in Immunochemistry and Coagulation Chemistry), Boston, MA, 1981 - 1984

Certifications:

American Board of Internal Medicine: Internal Medicine
American Board of Internal Medicine: Hematology

Professional society memberships:

American Federation of Clinical Research, 1990
American College of Physicians (Fellow) , 1991
American Society of Hematology, 1982
American Association for Cancer Research, 1987
European Haematology Association, 2007
International Society of Thrombosis and Haemostasis, 1998

Awards:

Dr. Liebman was voted a Top Doctor by Pasadena Magazine in 2011.